For instance, beyond the well-known BRCA mutations in breast cancer, alterations in genes such as BARD1, and pathogenic variants of RAD51C and RAD51D, reported to be associated with increased breast cancer risk, have also been identified [114]. This evidence concerns the gene RAD51D and breast carcinoma.